Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Lung Cancer Indicator Detection

NCT02612532 is registered in ClinicalTrials.gov with Owlstone Ltd as lead sponsor.

NCT NCT02612532
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02612532 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Lung Cancer Indicator Detection
Lead sponsor
Owlstone Ltd
Phase
Not applicable
Overall status
Completed
Start date
October 7, 2015
Completion date
December 22, 2022
Enrollment
2,603 (actual)
Sites
17

Conditions

As the registry lists them; a condition with its own page is linked.

lung cancer